Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Tuspetinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 175,273Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Hm43239, Hm-43239, 2569527-64-4, 2294874-49-8, 2-pyrimidinamine, 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethyl-1-piperazinyl)methyl)phenyl)-4-(6-methyl-1h-indol-3-yl)-, rel-, 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethylpiperazine-1-yl) methyl) phenyl)-4-(6-methyl-1hindol-3-yl) pyrimidin-2-amine
    Molecular Formula
    C29H33ClN6
    Molecular Weight
    501.1  g/mol
    InChI Key
    FZLSDZZNPXXBBB-KDURUIRLSA-N
    FDA UNII
    C0WUS7XXE9
    FLT3 Inhibitor HM43239 is a selective, reversible type I inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration of FLT3 inhibitor HM43239, it reversibly binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5-chloro-N-[3-cyclopropyl-5-[[(3R,5S)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine
    2.1.2 InChI
    InChI=1S/C29H33ClN6/c1-17-4-7-24-25(12-31-27(24)8-17)28-26(30)13-32-29(35-28)34-23-10-20(9-22(11-23)21-5-6-21)16-36-14-18(2)33-19(3)15-36/h4,7-13,18-19,21,31,33H,5-6,14-16H2,1-3H3,(H,32,34,35)/t18-,19+
    2.1.3 InChI Key
    FZLSDZZNPXXBBB-KDURUIRLSA-N
    2.1.4 Canonical SMILES
    CC1CN(CC(N1)C)CC2=CC(=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=C4C=CC(=C5)C)Cl)C6CC6
    2.1.5 Isomeric SMILES
    C[C@@H]1CN(C[C@@H](N1)C)CC2=CC(=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=C4C=CC(=C5)C)Cl)C6CC6
    2.2 Other Identifiers
    2.2.1 UNII
    C0WUS7XXE9
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Hm43239

    2. Hm-43239

    3. 2569527-64-4

    4. 2294874-49-8

    5. 2-pyrimidinamine, 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethyl-1-piperazinyl)methyl)phenyl)-4-(6-methyl-1h-indol-3-yl)-, Rel-

    6. 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethylpiperazine-1-yl) Methyl) Phenyl)-4-(6-methyl-1hindol-3-yl) Pyrimidin-2-amine

    7. Tuspetinib

    8. 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethylpiperazin-1-yl)methyl)phenyl)-4-(6-methyl-1h-indol-3-yl)pyrimidin-2-amine

    9. 5-chloro-n-[3-cyclopropyl-5-[[(3r,5s)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1h-indol-3-yl)pyrimidin-2-amine

    10. Unii-c0wus7xxe9

    11. Schembl21629038

    12. Gtpl12010

    13. Us10870639, Example 8

    14. Bdbm476700

    15. Glxc-25333

    16. Ex-a5352

    17. Example 8 [us10870639b2]

    18. Db15343

    19. Hy-145015

    20. Cs-0312139

    21. 5-chloro-n-(3-cyclopropyl-5-(((3r,5s)-3,5-dimethylpiperazine-1-yl)methyl)phenyl)-4-(6-methyl-1h-indole-3-yl)pyrimidine-2-amine

    22. 5-chloro-n-(3-cyclopropyl-5-(((3s,5r)-3,5-dimethylpiperazin-1-yl)methyl)phenyl)-4-(6-methyl-1h-indol-3-yl)pyrimidin-2-amine

    2.4 Create Date
    2018-12-16
    3 Chemical and Physical Properties
    Molecular Weight 501.1 g/mol
    Molecular Formula C29H33ClN6
    XLogP35.8
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count6
    Exact Mass500.2455228 g/mol
    Monoisotopic Mass500.2455228 g/mol
    Topological Polar Surface Area68.9 Ų
    Heavy Atom Count36
    Formal Charge0
    Complexity725
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1